Centre will consider Rs 100 crore bio-safety lab for Kerala: Harsh Vardhan

Bio-technology (BT) sector is expected to reach $100 crore in the next decade; India to be third-largest player by 2025

Harsh Vardhan
BS Reporter Kochi
Last Updated : May 18 2015 | 10:39 PM IST
Union Minister for Science and Technology Harsh Vardhan today said the Centre would actively consider Kerala government’s request for setting up a Rs 100-crore dedicated bio-safety lab for the study of virus.

“It is the government’s responsibility to ensure proper public health and to safeguard public interest. As soon as I return to Delhi, a feasibility study for setting up the bio-safety lab would be examined,” Harsh Vardhan said.

The Union Minister and Kerala chief minister Oommen Chandy were both present here on the occasion of dedicating Phase-I of Rajiv Gandhi Centre for Biotechnology (RGCB) Bio-Innovation Centre (BIC) at the Kinfra Film and Video Park at Kazhakootam near Thiruvananthapuram.  

He said the country’s bio-technology sector with an annual 70 per cent growth was expected to clock $100 billion revenue in the next 10 years. By 2025, India is set to be the third biggest global player in the field of bio-technology unveiling new innovative vaccines for prevention of diseases.

Meanwhile, Chandy, speaking on the need for a virus testing facility in the state, said, “A bio-safety lab would be beneficial not just for Kerala but for the entire south India. Disease diagnostics and testing is highly important as the state plays host to migratory birds and other animal species.”

He recalled the active role played by RGCB in providing diagnostics services when Kerala was hit by an epidemic recently, adding the testing of samples from Kerala was mostly being done at labs in Pune and Bhopal.

RGCB director M Radhakrishna Pillai said they planned to set up a 75-bed facility with the help of the Thiruvananthapuram Medical College’s Regional Cancer Centre in Phase  II of the BIC Aakulam centre.

The Phase-I facility, spread over 50,000 sft, has advanced platforms for studying the next generation genetic sequencing, high-end bio-imaging as well as a state-of-the-art molecular diagnostics facility for serving Kerala and neighbouring states.

The facility also signed an MoU with the Kerala State Council for Science, Technology and Environment enabling the Kottayam-based Srinivasa Ramanujam Institute for taking up basic sciences research at its facility.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 18 2015 | 8:45 PM IST

Next Story